Published data from Moderna COVID-19 vaccine trial show 94.1 percent efficacy

BOSTON — A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc. Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine can prevent symptomatic infection.…

Details

How did trauma centers respond to COVID-19? New processes provide care to trauma patients while keeping providers safe

December 30, 2020 – As the COVID-19 pandemic emerged, trauma centers faced unprecedented obstacles to providing care for injured patients. A look at steps taken by trauma centers in response to COVID-19 is provided by a survey in the January/February Journal for Healthcare Quality (JHQ), the peer-reviewed journal of the National Association for Healthcare Quality…

Details

U.S. Diet Guidelines Sidestep Scientific Advice to Cut Sugar and Alcohol

Rejecting the advice of its scientific advisers, the federal government has released new dietary recommendations that sound a familiar nutritional refrain, advising Americans to “make every bite count” while dismissing expert recommendations to sharply reduce consumption of sugar and alcoholic beverages. The “Dietary Guidelines for Americans” are updated every five years, and the latest iteration…

Details

Dating Without Alcohol

Spaces for Sober Singles After eliminating alcohol from their lives, some sober individuals exclusively date nondrinkers. Outside traditional dating apps, are online platforms like 12StepMatch, Love in Recovery and Single and Sober where it’s understood that no one drinks. Loosid app, a sober social network that started in 2018, offers boozeless guides, chat groups and…

Details